Privia Health Group, Inc. (NASDAQ:PRVA) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET
Company Participants
Robert Borchert - Senior Vice President- Investor & Corporate Communications
Parth Mehrotra - Chief Executive Officer
David Mountcastle - Chief Financial Officer
Conference Call Participants
A.J. Rice - UBS
Andrew Mok - Barclays
Richard Close - Canaccord Genuity
Jailendra Singh - Truist Securities
Jamie Perse - Goldman Sachs
Sameer Patel - Evercore ISI
Matthew Gillmor - KeyBanc
David Larsen - BTIG
Jeff Garro - Stephens
Ryan Langston - TD Cowen
Daniel Grosslight - Citi
Olivia Miles - Baird
Jack Slevin - Jeffries
Jessica Tassan - Piper Sandler
Thomas Kelliher - RBC Capital Markets
Adam Ron - Bank of America
Operator
Thank you for standing by. My name is Max and I'll be your conference operator for today. At this time, I would like to welcome everyone to the Privia Health Third Quarter Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. [Operator Instructions]
I would now like to turn the call over to Robert Borchert, SVP Investor and Corporate Communications. Please go ahead.
Robert Borchert
Thank you, Max and good morning everyone. Joining me are Parth Mehrotra, our Chief Executive Officer, and David Mountcastle, our Chief Financial Officer. This call is being webcast and can be accessed in the Investor Relations section of priviahealth.com.
Today's financial press release and slide presentation are posted on the Investor Relations pages of priviahealth.com. Following our prepared comments, we will open the line for questions. Please limit yourself to one question only, and return to the queue if you have a follow up, so we can get to as many questions as possible.
The financial results reported today are preliminary and are not final until our Form 10-Q for the third quarter ended September 30, 2024 is filed with the Securities and Exchange Commission. Some of the statements we will make today are forward-looking in nature based on our current expectations and view of our business as of November 7, 2024. Such statements, including those related to our future financial and operating performance and future business plans and objectives, are subject to risks and uncertainties that may cause actual results to differ materially. As a result, these statements should be considered along with the cautionary statements in today's press release and the risk factors described in our Company's most recent SEC filings.